Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -5.109% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCN(CC)c1ccc(/C=N/NS(=O)(=O)c2cccc([N+](=O)[O-])c2)cc1
b: Cc1ccc2c(c1)c(=O)c1c3n2CCN(C(=O)CCl)C3CC1
Answer: b. Cc1ccc2c(c1)c(=O)c1c3n2CCN(C(=O)CCl)C3CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2c(c1)c(=O)c1c3n2CCN(C(=O)CCl)C3CC1
Cc1ccc2c(c1)c(=O)c1c3n2CCN(C(=O)CCl)C3CC1
13-(2-chloroacetyl)-5-methyl-1,13-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-2(7),3,5,9(16)-tetraen-8-one